
Biocircuit Technologies Inc Profile last edited on: 5/12/2023
CAGE: 8BFM7
UEI: E9KLDNMNYJK5
Business Identifier: Noninvasive electrophysiology devices to monitor, control and repair peripheral nerves Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
1819 Peachtree Road Suite 205
Atlanta, GA 30309
Atlanta, GA 30309
(404) 433-9035 |
info@biocircuit.com |
www.biocircuit.com/ |
Location: Single
Congr. District: 05
County: Fulton
Congr. District: 05
County: Fulton
Public Profile
Spun out of Axion Biosystems - itself an Atlanta based, SBIR involved firm - Biosystems BioCircuit Technologies organizes around providing clinicians with simple-to-use devices providing non-invasive access to nerve activity. With the objective of enabling more precise diagnosis and individualized treatment, the firm develops noninvasive electrophysiology devices used to monitor, control, and repair peripheral nerves. Combining advanced hardware and proprietary algorithms, the technology is designed for simple and reliable clinical use that enables clinicians easily to access precise and accurate information about nerve activity - provide better, more accurate treatment for a variety of nerve-related health conditions. The firm's devices leverage multi-electrode arrays and proprietary algorithms for repairing peripheral nerves providing clinicians with a practical ability to diagnose health conditions earlier, track the progression of symptoms over time and deermine with precision the best treatments for the particular patient.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
15-19Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2023 | 1 | NIH | $1,887,020 | |
Project Title: Commercialization Readiness for Nerve Tape: a nerve repair coaptation aid | ||||
2023 | 2 | NIH | $3,934,090 | |
Project Title: Spinal Reflex Conditioning System for Enhancing Motor Function Recovery After Incomplete Spinal Cord Injury |
Key People / Management
Michelle Jarrard -- President, Chief Executive Officer
Isaac Perry Clements -- Chief Technology Officer
Jack Griffis -- Scientific Advisor (part time)
Daniel Hochman -- Research Engineer
Brandon Mark -- Director of Sales
Michael McKinnon -- Senior Biomedical Engineer
Dawson Reimer -- Nerve Tape Business Unit
James Ross -- Co-Founder & Senior Technical Advisor
Isaac Perry Clements -- Chief Technology Officer
Jack Griffis -- Scientific Advisor (part time)
Daniel Hochman -- Research Engineer
Brandon Mark -- Director of Sales
Michael McKinnon -- Senior Biomedical Engineer
Dawson Reimer -- Nerve Tape Business Unit
James Ross -- Co-Founder & Senior Technical Advisor
Company News
There are no news available.